Evidence map›Paper›PMID 33981950›Full record

ArticleJNCI cancer spectrum2021

Relation of Quantitative Histologic and Radiologic Breast Tissue Composition Metrics With Invasive Breast Cancer Risk.

Mustapha Abubakar, Shaoqi Fan, Erin Aiello Bowles, Lea Widemann, Máire A Duggan, Ruth M Pfeiffer, Roni T Falk, Scott Lawrence, Kathryn Richert-Boe, Andrew G Glass and 4 more

Open access · goldAbstract read
In one paragraph

Article in JNCI cancer spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Contribution of Prediagnostic Host Factors to Shaping the Stromal Microenvironment of Breast Cancer among Sub-Saharan African Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Mustapha AbubakarDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, USA.ORCID 0000-0003-3728-6535
Shaoqi FanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, USA.ORCID 0000-0001-5894-7510
Erin Aiello BowlesKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.ORCID 0000-0001-6287-7391
Lea WidemannDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, USA.
Máire A DugganDepartment of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0001-6625-7683
Ruth M PfeifferDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, USA.
Roni T FalkDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, USA.ORCID 0000-0001-5398-761X
Scott LawrenceMolecular and Digital Pathology Laboratory, Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc, Frederick, MD, USA.
Kathryn Richert-BoeKaiser Permanente Center for Health Research, Portland, OR, USA.
Andrew G GlassKaiser Permanente Center for Health Research, Portland, OR, USA.
Teresa M KimesKaiser Permanente Center for Health Research, Portland, OR, USA.
Jonine D FigueroaUsher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Scotland, UK.ORCID 0000-0002-5100-623X
Thomas E RohanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Gretchen L GierachDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, USA.ORCID 0000-0002-0165-5522
National Cancer Institute · USKaiser Permanente Center for Health Research · USAlbert Einstein College of Medicine · USKaiser Permanente Washington Health Research Institute · USLeidos (United States) · USUniversity of Calgary · CAUniversity of Edinburgh · GB

Funding

Group Health Cancer Research Program Research Specialist AwardR50CA211115 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI BOWLES, ERIN JANELLE AIELLO · 2017 to 2021
$919k
NCI NIH HHS R50 CA211115
6 · The paper itself

Abstract

Background: Benign breast disease (BBD) is a strong breast cancer risk factor, but identifying patients that might develop invasive breast cancer remains a challenge. Methods: By applying machine-learning to digitized hematoxylin and eosin-stained biopsies and computer-assisted thresholding to mammograms obtained circa BBD diagnosis, we generated quantitative tissue composition metrics and determined their association with future invasive breast cancer diagnosis. Archival breast biopsies and mammograms were obtained for women (18-86 years of age) in a case-control study, nested within a cohort of 15 395 BBD patients from Kaiser Permanente Northwest (1970-2012), followed through mid-2015. Patients who developed incident invasive breast cancer (ie, cases; n = 514) and those who did not (ie, controls; n = 514) were matched on BBD diagnosis age and plan membership duration. All statistical tests were 2-sided. Results: Increasing epithelial area on the BBD biopsy was associated with increasing breast cancer risk (odds ratio [OR] Conclusion: Among BBD patients, increasing epithelium-to-stroma proportion on BBD biopsies and percent MBD at BBD diagnosis were independently and jointly associated with increasing breast cancer risk. These findings were particularly striking for women with nonproliferative disease (comprising approximately 70% of all BBD patients), for whom relevant predictive biomarkers are lacking.

Indexed as

Diagnosis, Computer-AssistedSupervised Machine LearningAdultAgedAged, 80 and overAge FactorsBiopsyBreastBreast DensityBreast DiseasesBreast NeoplasmsCase-Control StudiesConfidence IntervalsFemaleHumansMammography

Identifiers

PMID33981950
PMCPMC8103888
OpenAlexW3161687379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.